Clinical trial
The Markers and Paracetamol Poisoning Study 2 - Early Diagnosis of Drug-induced Liver Injury Using Point of Care Detection of microRNA
NCT03497104 is registered in ClinicalTrials.gov with NHS Lothian as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Markers and Paracetamol Poisoning Study 2 - Early Diagnosis of Drug-induced Liver Injury Using Point of Care Detection of microRNA
- Lead sponsor
- NHS Lothian
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 1, 2018
- Completion date
- May 31, 2023
- Enrollment
- 464 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
paracetamol overdose